At a time when other drug makers are either consolidating or going slow on hiring; Dr Reddy's Laboratories and Mankind Pharma plan to add at least 1,000 personnel each in their sales and marketing teams in the coming fiscal. As far as Dr. Reddy’s Laboratories is concerned, it has ramped up its domestic field force to expand business primarily in the northern and eastern parts of the country. For Delhi-based Mankind Pharma, the focus is to push its new products, particularly in segments such as dermatology and cardiology, and gain market share to become the number one company in the Indian market by 2015. Two other Indian companies, Alkem and Lupin, also plan to add about 300 and 400 personnel each to their workforce next fiscal.
However, most other drug majors are looking at consolidation. Cipla plans to "optimise" its 7,000 sales force while GSK and Pfizer will consolidate its existing teams and conduct only a few "selective" or replacement hiring. Sanofi Aventis is also "right sizing" its team, following the addition of about 700 people through the acquisition of Universal Medicare last year.
Source: The Economic Times